Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials
Pierre Van Damme
Ilse De Coster; Isabel Leroux-Roels; Ananda S Bandyopadhyay; Christopher Gast; Kanchanamala Withanage; Katie Steenackers; Philippe De Smedt; Annelies Aerssens; Geert Leroux-Roels; M Steven Oberste; Jennifer L Konopka-Anstadt; William C Weldon; Alan Fix; John Konz; Rahnuma Wahid; John Modlin; Ralf Clemens; Sue Ann Costa Clemens; Novilia S Bachtiar; Pierre Van Damme